Graphical abstract from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells

Graphical abstract from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells

<p>Graphical abstract. A multi-omics analysis of the glioblastoma tumor microenvironment revealed that biglycan, predominantly expressed by inflammatory BTICs, drives tumor growth. The graphics were generated with Biorender.com.</p>

Na minha lista:

Detalhes bibliográficos
Autor principal:	Reza Mirzaei (15306062) (author)
Outros Autores:	Charlotte D'Mello (15306065) (author), Marina Liu (15306068) (author), Ana Nikolic (15306071) (author), Mehul Kumar (15306074) (author), Frank Visser (15306077) (author), Pinaki Bose (15306080) (author), Marco Gallo (8808401) (author), V. Wee Yong (15306083) (author)
Publicado em:	2025
Assuntos:	Cancer Tumor Biology Molecular and Cellular Biology CNS Cancers Gliomas, Glioblastomas Stem Cell Biology Cancer stem cells Tumor Heterogeneity
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados

Supplementary Table S1 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
Por: Reza Mirzaei (15306062)
Publicado em: (2025)

Supplementary Table S2 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
Por: Reza Mirzaei (15306062)
Publicado em: (2025)

Figure S1 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
Por: Michael Kilian (16697663)
Publicado em: (2025)

Figure S2 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
Por: Michael Kilian (16697663)
Publicado em: (2025)

Figure S3 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
Por: Michael Kilian (16697663)
Publicado em: (2025)

Supplementary Figures from Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
Por: Defne Bayik (14961098)
Publicado em: (2025)

Table S1 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table S2 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table S3 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table S4 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table S5 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table S6 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table S7 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma
Por: Isha Mondal (16721699)
Publicado em: (2025)

Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Por: Min Wu (14962986)
Publicado em: (2025)

Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Por: Min Wu (14962986)
Publicado em: (2025)

Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Por: Min Wu (14962986)
Publicado em: (2025)

Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Por: Min Wu (14962986)
Publicado em: (2025)

Data Sheet 1_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.csv
Por: Zhongyi Zhang (219440)
Publicado em: (2025)

Data Sheet 2_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.pdf
Por: Zhongyi Zhang (219440)
Publicado em: (2025)

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Por: Francesca Orzan (15055579)
Publicado em: (2025)

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Por: Francesca Orzan (15055579)
Publicado em: (2025)

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Por: Francesca Orzan (15055579)
Publicado em: (2025)

Graphical abstract.
Por: Ji-Xin Zhao (22056386)
Publicado em: (2025)

Supplementary Figure S1 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
Por: Sied Kebir (15048732)
Publicado em: (2025)

Supplementary Figure S2 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
Por: Sied Kebir (15048732)
Publicado em: (2025)

Supplementary Figure S3 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
Por: Sied Kebir (15048732)
Publicado em: (2025)

Supplementary Figure S4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
Por: Sied Kebir (15048732)
Publicado em: (2025)

Supplementary Tables S1-4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
Por: Sied Kebir (15048732)
Publicado em: (2025)

Table S2 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Por: Joseph Toker (15399882)
Publicado em: (2025)

Table S3 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Por: Joseph Toker (15399882)
Publicado em: (2025)

Table S4 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Por: Joseph Toker (15399882)
Publicado em: (2025)

Table S5 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Por: Joseph Toker (15399882)
Publicado em: (2025)

Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Por: Joseph Toker (15399882)
Publicado em: (2025)

Table S7 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Por: Joseph Toker (15399882)
Publicado em: (2025)

Table S8 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Por: Joseph Toker (15399882)
Publicado em: (2025)

Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
Por: Takeru Oka (15386810)
Publicado em: (2025)

Supplementary Table S1 from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
Por: Takeru Oka (15386810)
Publicado em: (2025)

Supplementary Table S1 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Por: Qingsheng Xu (17078830)
Publicado em: (2025)

Supplementary Table S3 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Por: Qingsheng Xu (17078830)
Publicado em: (2025)

Cannot write session to /tmp/vufind_sessions/sess_dfhbkcub9dm1c8tbmob4o3pk74